Non-infectious Pulmonary Diseases and HIV. (Q38819315)

6 September 2017

Non-infectious Pulmonary Diseases and HIV. (English)

1 reference

6 September 2017

M Triplette

1

0 references

Kristina Crothers

object named as

K Crothers

series ordinal

2

0 references

author name string

E F Attia

series ordinal

3

1 reference

6 September 2017

28 April 2016

1 reference

6 September 2017

Current HIV/AIDS reports

1 reference

6 September 2017

13

1 reference

6 September 2017

3

1 reference

6 September 2017

140-148

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-016-0313-0

6 September 2017

0 references

cites work

Respiratory infection complicating HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Elevated incidence of lung cancer among HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Increased COPD among HIV-positive compared to HIV-negative veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Impact of HIV infection and smoking on lung immunity and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV infection is associated with an increased risk for lung cancer, independent of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Noninfectious pulmonary complications of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cancer as a cause of death among people with AIDS in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Epidemic of lung cancer in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Age at cancer diagnosis among persons with AIDS in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV infection, immunodeficiency, viral replication, and the risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Lung cancer incidence and survival among HIV-infected and uninfected women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Maintaining lung health with longstanding HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Current questions in HIV-associated lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART era

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cancer treatment disparities in HIV-infected individuals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

21 January 2018

Lung Cancer Statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Stages of the cigarette epidemic on entering its second century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

The increasing burden of HIV-associated malignancies in resource-limited regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cancer and HIV infection in referral hospitals from four West African countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Association between obstructive lung disease and markers of HIV infection in a high-risk cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Pulmonary function in an international sample of HIV-positive, treatment-naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Analysis of the lung microbiome in the "healthy" smoker and in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

The lung tissue microbiome in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

The microbiome and the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Widespread colonization of the lung by Tropheryma whipplei in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Contributors to diffusion impairment in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Respiratory symptoms among HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV infection is associated with reduced pulmonary diffusing capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

The burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Cellular and molecular mechanisms of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Absolute leukocyte telomere length in HIV-infected and uninfected individuals: evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV Associated Chronic Obstructive Pulmonary Disease in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an African country with low level of tobacco smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Echocardiographic abnormalities and associated factors in a cohort of asymptomatic HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Human immunodeficiency virus-associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Human immunodeficiency virus-associated pulmonary arterial hypertension: considerations for pulmonary vascular diseases in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Inflammatory mechanisms in HIV-associated pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Relationship between endothelin-1 levels and pulmonary arterial hypertension in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Prevalence and severity of ventricular dysfunction in patients with HIV-related pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Contributions of pulmonary hypertension to HIV-related cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Injection drug use as a "second hit" in the pathogenesis of HIV-associated pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV-associated pulmonary arterial hypertension: from bedside to the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV protease inhibitors in pulmonary hypertension: rationale and design of a pilot trial in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

HIV and the heart: the impact of antiretroviral therapy: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Recent advances in HIV-associated cardiovascular diseases in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Pulmonary vascular disease associated with schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Schistosomiasis causes remodeling of pulmonary vessels in the lung in a heterogeneous localized manner: Detailed study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Behavioral Interventions for Tobacco Use in HIV-Infected Smokers: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-016-0313-0

Gender Differences in Pulmonary Function, Respiratory Symptoms, and Macrophage Proteomics among HIV-Infected Smokers

21 January 2018

1 reference

12 December 2020

Excess cancers among HIV-infected people in the United States

1 reference

12 December 2020

Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.

1 reference

12 December 2020

High prevalence of pulmonary arterial hypertension in a cohort of asymptomatic HIV-infected patients.

1 reference

12 December 2020

Impact of HIV on lung tumorigenesis in an animal model

1 reference

12 December 2020

Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients.

1 reference

12 December 2020

HIV and smoking: associated risks and prevention strategies

1 reference

12 December 2020

10.1007/S11904-016-0313-0

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

27121734